Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal
Cyclica Inc., a neo-biotech that is unlocking the protein universe to discover the medicines of tomorrow, is developing new, non-hormonal...
Cyclica receives CAD$2.4M grant for a multi-targeted drug discovery program to advance non-hormonal
Xpansiv Enters Agreement to Acquire APX to Integrate Global ESG Market Infrastructure
Space startup Wyvern raises $4.5M and joins YC's latest cohort
Liver Health Company Sonic Incytes Successfully Completes Series A Raise of US$7.3M
GrubMarket raises 145MM to accelerate growth
AI Drug Discovery Company Cyclica Featured in Globe and Mail
ApplyBoard Named One of Canada’s Fastest-Growing Companies by Deloitte for Second Year in a Row